MedPath

Herbs, Brain Imaging and Memory study.

Not Applicable
Completed
Conditions
Cognitive performance
Mental Health - Studies of normal psychology, cognitive function and behaviour
Alternative and Complementary Medicine - Herbal remedies
Registration Number
ACTRN12619001425189
Lead Sponsor
Central Queensland University
Brief Summary

This study assessed whether a multi-ingredient herbal supplement containing Bacopa monniera (BM), Panax quinquefolius ginseng (PQ) and Whole Coffee Fruit Extract (WCFE) could enhance cognitive performance and brain activation during tasks of memory and attention. In a randomized, double-blind, placebo-controlled, between-group study, 40 healthy adults between 18-60 years completed cognitive tasks at baseline and following active or placebo supplement consumption in a 2 hour period. During the cognitive testing, changes in brain activity were continuously measured using non-invasive imaging, functional near infrared spectroscopy (fNIRS). The results show significant improvement in tasks of working memory following active supplement consumption compared to placebo and improved performance was associated with changes in amount of brain activity required to complete the task. The results were independent of background demographics variables.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

Healthy adults aged 18- 60 years, without major medical conditions, such as diabetes,
cardiovascular disease, acute or terminal illness; BMI below 35, moderate alcohol consumption, no medication changes for the management of
health conditions within last 6 weeks, no current or recent history of taking medications for mood disorders and/or previous history of neurological conditions as these conditions have been shown to be related to impaired cognitive performance.

Exclusion Criteria

Pre-existing medical conditions, including diabetes, cardiovascular disease, medication changes for the management of health conditions within last 6 weeks, current or recent history of taking medications for mood disorders and/or previous history of neurological conditions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath